J. Ostrander

发表

Tumor and Stem Cell Biology Cancer Research Optical Redox Ratio Differentiates Breast Cancer Cell Lines Based on Estrogen Receptor Status

V. Seewaldt, J. Ostrander, C. McMahon, 2010 .

Morphologically Normal-AppearingMammary Epithelial Cells Obtained from High-RiskWomen Exhibit Methylation Silencing of INK 4 a / ARF

T. Tlsty, J. Ostrander, C. Zalles, 2007 .

Morphologically Normal-Appearing Mammary Epithelial Cells Obtained from High-Risk Women Exhibit Methylation Silencing of INK4a/ARF

V. Seewaldt, T. Tlsty, J. Ostrander, 2007, Clinical Cancer Research.

Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.

J. Ostrander, C. Lange, A. R. Daniel, 2007, Cancer research.

Light scattering measurements of subcellular structure provide noninvasive early detection of chemotherapy-induced apoptosis.

Adam Wax, Kevin J Chalut, Michael G Giacomelli, 2009, Cancer research.

The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation.

H. You, J. Ostrander, G. Blobe, 2007, Carcinogenesis.

CpG Island Tumor Suppressor Promoter Methylation in Non-BRCA-Associated Early Mammary Carcinogenesis

W. Barry, V. Weaver, V. Seewaldt, 2009, Cancer Epidemiology Biomarkers & Prevention.

Monitoring of receptor dimerization using plasmonic coupling of gold nanoparticles.

J. Ostrander, A. Wax, M. Crow, 2011, ACS nano.

Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF–driven Signaling Axis

Yan Peng, G. Raj, J. Cidlowski, 2018, Molecular Cancer Research.

ESR1 Promoter Hypermethylation Does Not Predict Atypia in RPFNA nor Persistent Atypia after 12 Months Tamoxifen Chemoprevention

V. Seewaldt, J. Ostrander, S. Lem, 2008, Cancer Epidemiology Biomarkers & Prevention.

PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer

J. Ostrander, B. Welm, Camila O. dos Santos, 2021, Oncogene.

PELP1/SRC-3-dependent regulation of metabolic kinases drives therapy resistant ER+ breast cancer

J. Ostrander, B. Welm, C. Lange, 2020, bioRxiv.

PELP1: A review of PELP1 interactions, signaling, and biology

J. Ostrander, C. Lange, A. R. Daniel, 2014, Molecular and Cellular Endocrinology.

Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer.

J. Ostrander, C. Lange, A. R. Daniel, 2016, Journal of molecular endocrinology.

Steroid Receptors as MAPK Signaling Sensors in Breast Cancer: Let the Fates Decide.

J. Ostrander, C. Lange, Thu H. Truong, 2020, Journal of molecular endocrinology.

Cytoplasmic Localization of Proline, Glutamic Acid, Leucine-rich Protein 1 (PELP1) Induces Breast Epithelial Cell Migration through Up-regulation of Inhibitor of κB Kinase ϵ and Inflammatory Cross-talk with Macrophages*

J. Ostrander, K. Schwertfeger, T. Knutson, 2016, The Journal of Biological Chemistry.

Cancer Stem Cell Phenotypes in ER+ Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes

J. Ostrander, N. Brady, C. Lange, 2018, Molecular Cancer Research.

Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes

D. Yee, Yan Peng, G. Raj, 2014, Oncogene.

Abstract 3572: Unliganded progesterone receptors augment estrogen-induced growth of breast cancer cells via co-regulation of estrogen receptor target genes.

D. Yee, J. Ostrander, C. Lange, 2013 .

Evidence for Phenotypic Plasticity in Aggressive Triple-Negative Breast Cancer: Human Biology Is Recapitulated by a Novel Model System

R. Cardiff, J. Delrow, K. Mrózek, 2012, PloS one.

Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK

J. Ostrander, C. Lange, Kristopher A. Lofgren, 2011, Breast Cancer Research.

Brk/PTK6 signaling in normal and cancer cell models.

J. Ostrander, C. Lange, A. R. Daniel, 2010, Current opinion in pharmacology.

Regulated Association of Protein Kinase B/Akt with Breast Tumor Kinase*

J. Ostrander, C. Lange, Emily J. Faivre, 2005, Journal of Biological Chemistry.

Stress sensing within the breast tumor microenvironment: how glucocorticoid receptors live in the moment.

J. Ostrander, C. Lange, Thu H. Truong, 2021, Essays in biochemistry.

ESR 1 promoter hypermethylation does not predict atypia in random periareolar fine needle aspiration nor persistent atypia after 12 months tamoxifen chemoprevention

V. Seewaldt, J. Ostrander, S. Lem, 2008 .

Cytoplasmic PELP1 and ERRgamma Protect Human Mammary Epithelial Cells from Tam-Induced Cell Death

V. Seewaldt, J. Ostrander, Tarah M Regan Anderson, 2015, PloS one.

Linkage of progestin and epidermal growth factor signaling: Phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth

J. Ostrander, C. Lange, Andrew Skildum, 2007, Steroids.

Preferential accumulation of 5-aminolevulinic acid-induced protoporphyrin IX in breast cancer: a comprehensive study on six breast cell lines with varying phenotypes.

S. Yazdanfar, N. Ramanujam, J. Ostrander, 2010, Journal of biomedical optics.

Review of the Application of T-Matrix Calculations for Determining the Structure of Cell Nuclei With Angle-Resolved Light Scattering Measurements

J. Ostrander, M. Giacomelli, K. Chalut, 2010, IEEE Journal of Selected Topics in Quantum Electronics.

Application of the T-matrix method to determine the structure of spheroidal cell nuclei with angle-resolved light scattering.

Adam Wax, Kevin J Chalut, Michael G Giacomelli, 2008, Optics letters.

T-matrix based inverse light scattering analysis using angle resolved low coherence interferometry

Michael G. Giacomelli, Adam Wax, Julie H. Ostrander, 2009, BiOS.

Hyperspectral molecular imaging of multiple receptors using immunolabeled plasmonic nanoparticles.

Adam Wax, Kevin Seekell, Stella M. Marinakos, 2011, Journal of biomedical optics.

Detection of structural and functional changes in biological materials using angle-resolved low coherence interferometry

Adam Wax, Julie H. Ostrander, Kevin J. Chalut, 2008, SPIE BiOS.

Hyperspectral molecular imaging of multiple receptors using immunolabeled plasmonic nanoparticles

Adam Wax, Matthew J. Crow, Kevin Seekell, 2011, BiOS.

Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines

Julie H. Ostrander, Nirmala Ramanujam, J. Quincy Brown, 2011, Breast Cancer Research and Treatment.

AWARD NUMBER: W81XWH-08-1-0240 TITLE: Multidisciplinary Biomarkers of Early Mammary Carcinogenesis

J. Ostrander, 2010 .

Steroid Receptors as MAPK Signaling Sensors in Breast Cancer: Let the Fates Decide.

J. Ostrander, C. Lange, Thu H. Truong, 2020, Journal of molecular endocrinology.

Monitoring of receptor dimerization using plasmonic coupling of gold nanoparticles.

J. Ostrander, A. Wax, M. Crow, 2011, ACS nano.